Jpmorgan Chase & CO Globus Medical Inc Transaction History
Jpmorgan Chase & CO
- $1.51 Trillion
- Q3 2025
A detailed history of Jpmorgan Chase & CO transactions in Globus Medical Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,681,957 shares of GMED stock, worth $311 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,681,957
Previous 3,681,957
-0.0%
Holding current value
$311 Million
Previous $211 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding GMED
# of Institutions
548Shares Held
118MCall Options Held
279KPut Options Held
45.9K-
Vanguard Group Inc Valley Forge, PA10.6MShares$896 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$873 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07.55MShares$638 Million0.21% of portfolio
-
Sculptor Capital LP New York, NY3.5MShares$296 Million5.4% of portfolio
-
State Street Corp Boston, MA3.46MShares$292 Million0.01% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $6.51B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...